Lilly misses profit projects as sales of diabetes drug slow
|
October 28, 2020 12:03 AM
INDIANAPOLIS (AP) — Eli Lilly and Co. is reporting third-quarter net income of $1.21 billion.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
